Walid Abi-Saab, @ Galapagos

Galapagos: To the clinic

Mechelen-based biotech Galapagos NV has appointed Walid Abi-Saab to the role of Chief Medical Officer. 

Abi-Saab joins from Shire Pharmaceuticals, where he held various clinical development leadership positions, most recently Group Vice President, Global Clinical Development - Therapeutic Area Head, Gastro-intestinal, Endocrinology and Metabolism. Before Shire, the trained psychiatrist led the clinical development activities at Novartis, Abbott Laboratories, and Pfizer.